Nicotinamide riboside supplementation ameliorated post-ovulatory oocyte quality decline
Reproduction · 01.01.2023 · 165 (1) · 103-111
DOI: 10.1530/rep-22-0095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, online erschienen am 02.12.2022. Verfasst von Hui Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: NAD, Oocytes. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
In brief Oocyte quality and its NAD+ level decrease with time during in vitro culture. This study shows that nicotinamide riboside (NR) supplementation improves early embryonic development potential in post-ovulatory oocytes by decreasing the reactive oxygen species (ROS) levels and reducing DNA damage and apoptosis which could potentially increase the success rate of assisted reproductive technology (ART). Abstract The quality of post-ovulatory oocytes deteriorates over time, impacting the outcome of early embryonic development during human ART. We and other groups have found that NAD+, a prominent redox cofactor and enzyme substrate, decreases in both aging ovaries and oocytes. In this study, we found that the NAD+ levels decreased in the post-ovulatory mouse oocytes during in vitro culture and this decrease was partly prevented by NR supplementation. NR treatmenty restored MII oocyte quality and enhanced the early embryonic development potential of post-ovulatory oocytes via alleviating mitochondrial dysfunction and maintaining normal spindle/chromosome structure. Also, treatment with NR decreased ROS levels and reduced DNA damage and apoptosis in post-ovulatory oocytes. Taken together, our findings indicated that NR supplementation increases the oocyte quality and early embryonic development potential in post-ovulatory oocytes which could potentially increase the success rate of ART.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Henan Provincial Obstetrical and Gynecological Diseases (Reproductive Medicine) Clinical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Hui Li, Xinxin Zeng, Qingling Yang
Zitieren
APA
Li, H., Wang, H., Xu, J., Zeng, X., Sun, Y., & Yang, Q. (2023). Nicotinamide riboside supplementation ameliorated post-ovulatory oocyte quality decline. Reproduction, 165(1), 103-111. https://doi.org/10.1530/rep-22-0095
Vancouver
Li H, Wang H, Xu J, Zeng X, Sun Y, Yang Q. Nicotinamide riboside supplementation ameliorated post-ovulatory oocyte quality decline. Reproduction. 2023;165(1):103-111. doi:10.1530/rep-22-0095
BibTeX
@article{Li2023,
author = {Li, Hui and Wang, Huan and Xu, Jianmin and Zeng, Xinxin and Sun, Yingpu and Yang, Qingling},
title = {Nicotinamide riboside supplementation ameliorated post-ovulatory oocyte quality decline},
journal = {Reproduction},
year = {2023},
volume = {165},
number = {1},
pages = {103--111},
doi = {10.1530/rep-22-0095}
}
EUVIMED